Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older
2016 · New England Journal of Medicine · 1,010 citations
https://doi.org/10.1056/nejmoa1603800
L
Lars Rombo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
3.6K
Citations
29
h-index
46
i10-index
Lars Rombo is an academic researcher from Uppsala University. The author has contributed to research in topics: Herpesvirus Infections and Treatments & Hepatitis Viruses Studies and Epidemiology & Travel-related health issues. The author has an h-index of 29, co-authored 54 publications.
ORCID: 0000-0002-5859-3158Papers by this author
worksLong-term immunogenicity and safety of an investigational herpes zoster subunit vaccine in older adults
2015 · Vaccine · 121 citations
https://doi.org/10.1016/j.vaccine.2015.09.073
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70
2021 · Clinical Infectious Diseases · 90 citations
https://doi.org/10.1093/cid/ciab629
Hepatitis A vaccine for immunosuppressed patients with rheumatoid arthritis: A prospective, open-label, multi-centre study
2014 · Travel Medicine and Infectious Disease · 78 citations
https://doi.org/10.1016/j.tmaid.2014.01.005
Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials
2019 · Vaccine · 61 citations
https://doi.org/10.1016/j.vaccine.2019.03.043
Non-typeable Haemophilus influenzae protein vaccine in adults with COPD: A phase 2 clinical trial
2019 · Vaccine · 52 citations
https://doi.org/10.1016/j.vaccine.2019.07.100
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat